IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AMY L FEIST

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1659606267
CMS profile
10750349
Location
ALEDO, IL

General Payments · PY2021–2024

$2,473.12

  • Reported across 146 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$937.10

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Nurse Practitioner IL All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $937.10 51

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $208.45 10
ABBVIE INC. $97.06 5
Exact Sciences Corporation $84.04 5
Boehringer Ingelheim Pharmaceuticals, Inc. $70.80 3
PFIZER INC. $64.86 4
Teva Pharmaceuticals USA, Inc. $64.48 4
Otsuka America Pharmaceutical, Inc. $62.05 4
Supernus Pharmaceuticals, Inc. $53.36 3
Lilly USA, LLC $48.59 3
NOVARTIS PHARMACEUTICALS CORPORATION $47.86 2
Amgen Inc. $34.10 2
E.R. Squibb & Sons, L.L.C. $33.70 2
Kyowa Kirin, Inc. $24.15 1
Takeda Pharmaceuticals U.S.A., Inc. $15.28 1
Novo Nordisk AS $14.87 1
Stryker Corporation $13.45 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $375.64 26
PY2022 $495.48 31
PY2023 $664.90 38
PY2024 $937.10 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $24.38 01/30/2024 Food and Beverage Undisputed 01/23/2026 1107095010 CMS
ABBVIE INC. $21.84 07/22/2024 Food and Beverage Undisputed 01/23/2026 1107095012 CMS
ABBVIE INC. $17.24 10/21/2024 Food and Beverage Undisputed 01/23/2026 1107095014 CMS
ABBVIE INC. $17.04 11/12/2024 Food and Beverage Undisputed 01/23/2026 1107095016 CMS
ABBVIE INC. $16.56 12/10/2024 Food and Beverage Undisputed 01/23/2026 1107095018 CMS
Amgen Inc. $14.87 02/07/2024 Food and Beverage Undisputed 01/23/2026 1115617914 CMS
Amgen Inc. $19.23 06/26/2024 Food and Beverage Undisputed 01/23/2026 1115617921 CMS
AstraZeneca Pharmaceuticals LP $19.60 02/15/2024 Food and Beverage Undisputed 01/23/2026 1104492220 CMS
AstraZeneca Pharmaceuticals LP $23.93 02/27/2024 Food and Beverage Undisputed 01/23/2026 1105387689 CMS
AstraZeneca Pharmaceuticals LP $24.87 03/06/2024 Food and Beverage Undisputed 01/23/2026 1105353498 CMS
AstraZeneca Pharmaceuticals LP $13.95 03/14/2024 Food and Beverage Undisputed 01/23/2026 1105888609 CMS
AstraZeneca Pharmaceuticals LP $14.36 04/02/2024 Food and Beverage Undisputed 01/23/2026 1104240413 CMS
AstraZeneca Pharmaceuticals LP $33.93 04/24/2024 Food and Beverage Undisputed 01/23/2026 1104237107 CMS
AstraZeneca Pharmaceuticals LP $15.07 05/09/2024 Food and Beverage Undisputed 01/23/2026 1104435099 CMS
AstraZeneca Pharmaceuticals LP $17.79 06/19/2024 Food and Beverage Undisputed 01/23/2026 1104380903 CMS
AstraZeneca Pharmaceuticals LP $24.40 10/14/2024 Food and Beverage Undisputed 01/23/2026 1105786632 CMS
AstraZeneca Pharmaceuticals LP $20.55 12/11/2024 Food and Beverage Undisputed 01/23/2026 1105833759 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.30 01/18/2024 Food and Beverage Undisputed 01/23/2026 1118099662 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.27 06/13/2024 Food and Beverage Undisputed 01/23/2026 1118099660 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.23 08/29/2024 Food and Beverage Undisputed 01/23/2026 1118099664 CMS
E.R. Squibb & Sons, L.L.C. $14.78 04/08/2024 Food and Beverage Undisputed 01/23/2026 1101220912 CMS
E.R. Squibb & Sons, L.L.C. $18.92 10/17/2024 Food and Beverage Undisputed 01/23/2026 1101220940 CMS
Exact Sciences Corporation $15.35 01/04/2024 Food and Beverage Undisputed 01/23/2026 1114492667 CMS
Exact Sciences Corporation $13.53 02/15/2024 Food and Beverage Undisputed 01/23/2026 1114492675 CMS
Exact Sciences Corporation $16.92 05/30/2024 Food and Beverage Undisputed 01/23/2026 1114492680 CMS
Exact Sciences Corporation $21.63 06/17/2024 Food and Beverage Undisputed 01/23/2026 1114492686 CMS
Exact Sciences Corporation $16.61 11/14/2024 Food and Beverage Undisputed 01/23/2026 1114492691 CMS
Kyowa Kirin, Inc. $24.15 11/09/2024 Food and Beverage Undisputed 01/23/2026 1127046533 CMS
Lilly USA, LLC $13.64 04/30/2024 Food and Beverage Undisputed 01/23/2026 1135467927 CMS
Lilly USA, LLC $14.75 07/30/2024 Food and Beverage Undisputed 01/23/2026 1135495818 CMS
Lilly USA, LLC $20.20 12/06/2024 Food and Beverage Undisputed 01/23/2026 1135467925 CMS
Novartis Pharmaceuticals Corporation $22.82 01/22/2024 Food and Beverage Undisputed 01/23/2026 1086905197 CMS
Novartis Pharmaceuticals Corporation $25.04 07/08/2024 Food and Beverage Undisputed 01/23/2026 1086905201 CMS
Novo Nordisk Inc $14.87 11/25/2024 Food and Beverage Undisputed 01/23/2026 1100593124 CMS
Otsuka America Pharmaceutical, Inc. $14.38 02/12/2024 Food and Beverage Undisputed 01/23/2026 1119069660 CMS
Otsuka America Pharmaceutical, Inc. $13.62 04/04/2024 Food and Beverage Undisputed 01/23/2026 1119069662 CMS
Otsuka America Pharmaceutical, Inc. $17.13 08/05/2024 Food and Beverage Undisputed 01/23/2026 1119069664 CMS
Otsuka America Pharmaceutical, Inc. $16.92 12/02/2024 Food and Beverage Undisputed 01/23/2026 1119069666 CMS
PFIZER INC. $15.41 02/22/2024 Food and Beverage Undisputed 01/23/2026 1131076385 CMS
PFIZER INC. $14.82 05/02/2024 Food and Beverage Undisputed 01/23/2026 1131318766 CMS
PFIZER INC. $14.61 11/07/2024 Food and Beverage Undisputed 01/23/2026 1131210712 CMS
PFIZER INC. $20.02 11/08/2024 Food and Beverage Undisputed 01/23/2026 1131216739 CMS
Stryker Corporation $13.45 06/11/2024 Food and Beverage Undisputed 01/23/2026 1120031171 CMS
Supernus Pharmaceuticals, Inc. $19.55 04/04/2024 Food and Beverage Undisputed 01/23/2026 1147891626 CMS
Supernus Pharmaceuticals, Inc. $14.02 05/04/2024 Food and Beverage Undisputed 01/23/2026 1147891624 CMS
Supernus Pharmaceuticals, Inc. $19.79 06/04/2024 Food and Beverage Undisputed 01/23/2026 1147891628 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.28 01/25/2024 Food and Beverage Undisputed 01/23/2026 1137741800 CMS
Teva Pharmaceuticals USA, Inc. $15.29 01/16/2024 Food and Beverage Undisputed 01/23/2026 1151694056 CMS
Teva Pharmaceuticals USA, Inc. $16.77 04/23/2024 Food and Beverage Undisputed 01/23/2026 1151694107 CMS
Teva Pharmaceuticals USA, Inc. $15.21 06/20/2024 Food and Beverage Undisputed 01/23/2026 1151694162 CMS
Teva Pharmaceuticals USA, Inc. $17.21 08/29/2024 Food and Beverage Undisputed 01/23/2026 1151694213 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.